Publications by authors named "Mar Luque Luna"

Article Synopsis
  • - The study analyzed the survival rate and interruption risks of adalimumab (ADA) treatment in 539 adult patients with hidradenitis suppurativa (HS), providing insights before and after the COVID-19 pandemic.
  • - Findings revealed that about 39.92% of patients interrupted ADA, with the main reasons being inefficacy (51.69%) and adverse effects (21.35%); ADA showed a median overall drug survival of 56.2 months.
  • - Factors like female gender, prolonged HS diagnosis, and higher HS severity correlated with decreased ADA survival, while post-pandemic trends included younger patients starting treatment at a lower HS stage.
View Article and Find Full Text PDF
Article Synopsis
  • Sweet syndrome is a skin condition linked to various medical issues, with a study in Spain analyzing 93 patients from 2001 to 2021 to uncover its characteristics and associations with malignancy and other disorders.* -
  • The majority of cases were either idiopathic, associated with malignancies like acute myeloid leukaemia, or reactive to infections, with specific symptoms and histological types identified, showing that pain and nodules relate to subcutaneous-Sweet syndrome.* -
  • Key findings indicate that male sex, fever, and other clinical factors are linked to malignancy in Sweet syndrome patients, suggesting that careful monitoring and a 6-month follow-up are important for those experiencing relapses, especially with myelodys
View Article and Find Full Text PDF